Skip to main content
CLDI logo

CLDI · Calidi Biotherapeutics, Inc. · Debt

Track CLDI — free
$0.48 -0.03 (-4.97%)
Market Cap
$1.74M
Shares
3.45M
Volume · Nov 20 44.43K Avg daily vol (3M) 100.86K

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Read debt and covenant terms in your AI or your code through MCP and the API →

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Finance lease liabilities 2026-06-30 USD 328,000 10-Q filed 2026-08-13
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current finance lease liabilities
USD 167,000
Noncurrent finance lease liabilities
USD 161,000
Long-term debt, including current maturities 2026-06-30 USD 600,000 10-Q filed 2026-08-13
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current portion of long-term debt
USD 45,000
Operating lease liabilities 2026-06-30 USD 1,014,000 10-Q filed 2026-08-13
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current operating lease liabilities
USD 1,009,000
Noncurrent operating lease liabilities
USD 5,000
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1855485 CUSIP 320703507 13F (30d) 24 filings 19 filers Visit website Investor relations